Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Reed

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
The American Journal of Tropical Medicine and Hygiene|September 28, 1998
Serodiagnosis and epidemiology of visceral leishmaniasis in TurkeyS Ozensoy, Y Ozbel, N Turgay, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral LeishmaniasisR Badaró, C Nascimento, J S Carvalho, et al.
The American Journal of Tropical Medicine and Hygiene|December 1, 1990
An improved serodiagnostic procedure for visceral leishmaniasisS G Reed, W G Shreffler, J M Burns, et al.
The Journal of Experimental Medicine|April 1, 1995
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12Y A Skeiky, J A Guderian, D R Benson, et al.
The Journal of Infectious Diseases|August 1, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasisR Badaró, C Nascimento, J S Carvalho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
IL-12 enhances Th1-type responses in human Leishmania donovani infectionsH W Ghalib, J A Whittle, M Kubin, et al.
The Journal of Experimental Medicine|November 1, 1995
Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophagesA Campos-Neto, L Soong, J L Cordova, et al.
The Journal of Clinical Investigation|July 1, 1993
Interleukin 10 production correlates with pathology in human Leishmania donovani infectionsH W Ghalib, M R Piuvezam, Y A Skeiky, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2013
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasisA C Vallur, M S Duthie, C Reinhart, et al.
The Journal of Infectious Diseases|July 7, 2000
Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivityR N Coler, Y A Skeiky, P J Ovendale, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
The American Journal of Tropical Medicine and Hygiene|September 28, 1998
Serodiagnosis and epidemiology of visceral leishmaniasis in TurkeyS Ozensoy, Y Ozbel, N Turgay, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral LeishmaniasisR Badaró, C Nascimento, J S Carvalho, et al.
The American Journal of Tropical Medicine and Hygiene|December 1, 1990
An improved serodiagnostic procedure for visceral leishmaniasisS G Reed, W G Shreffler, J M Burns, et al.
The Journal of Experimental Medicine|April 1, 1995
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12Y A Skeiky, J A Guderian, D R Benson, et al.
The Journal of Infectious Diseases|August 1, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasisR Badaró, C Nascimento, J S Carvalho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
IL-12 enhances Th1-type responses in human Leishmania donovani infectionsH W Ghalib, J A Whittle, M Kubin, et al.
The Journal of Experimental Medicine|November 1, 1995
Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophagesA Campos-Neto, L Soong, J L Cordova, et al.
The Journal of Clinical Investigation|July 1, 1993
Interleukin 10 production correlates with pathology in human Leishmania donovani infectionsH W Ghalib, M R Piuvezam, Y A Skeiky, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2013
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasisA C Vallur, M S Duthie, C Reinhart, et al.
The Journal of Infectious Diseases|July 7, 2000
Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivityR N Coler, Y A Skeiky, P J Ovendale, et al.
Pageof 17